Top Banner

of 13

20110930 - First Reit - Sias

Apr 07, 2018

Download

Documents

Kyith
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/4/2019 20110930 - First Reit - Sias

    1/13

    Page 1 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    IInnccrreeaassee EExxppoossuurreeFlagship To Medical Tourism in Indonesia

    S$0.965

    S$0.765

    Intrinsic Value

    Prev Close

    Main ActivitiesFirst Real Estate Investment Trust (First REIT)invests in a diversified portfolio of income producingreal estate used for healthcare and/or healthcare-related purposes. The Companys assets are locatedin Singapore, Korea and Indonesia.

    Financial Highlights(Y/E Dec) S$m FY09 FY10 FY11F

    Gross Revenue 30.2 30.3 53.0

    Net Prop Income 36.0 60.5 46.0

    Distr Earnings 21.0 21.3 41.7

    Distr Per Unit(S$) 0.076 0.066 0.067

    Distribution Yield 9.1% 7.9% 8.7%

    Source: Company, Bloomberg, SIAS Research Estimates

    Key ratios (FY11F)

    PER 10.5

    P/BV 1.0

    ROE (%) 9.6

    ROA (%) 7.1

    Debt / Equity 0.25

    Source: SIAS Research Estimates

    Indexed Price Chart

    Green (FSSTI)White (First REIT)

    Source: Bloomberg

    52wks High-Low S$0.840 /S$0.650

    Number of Shares 626.4m

    Market Capitalization S$482.33m

    Analyst:SIAS [email protected]: 6227 2107

    We wereinvited to First REITs (FREIT) Analyst Indonesia

    trip in late September 2011 and were presented a

    compelling story on how FREIT intends to capitalize on the

    growth of medical tourism in Indonesia and the untapped

    domestic demand. Out of the four FREIT assets we visited,

    we were most impressed with Mochtar Riady

    Comprehensive Cancer Centre (MRCCC) and are

    expecting it to further contribute to FREITs profit numbersmoving forward. We maintain our Increase Exposure

    rating on FREIT with an upgraded intrinsic value of S$0.965.

    Site Visit Summary:

    Updating ourselves on the operations of FREIT:

    Our trip was fulfulling as we keep up with Siloam

    Hospitals Group (SHG), the operator of FREITs

    assets. SHG intends to be a dominant provider of

    specialised healthcare services, appealing to

    Indonesians who seek these services abroad. Moving

    forward, SHG may want to further capitalise on their

    technological advantage to be the flagship to medical

    tourism in Indonesia.

    Update on latest Indonesian acquisition, MRCCC:

    MRCCC is the latest Indonesian acquisition by FREIT

    funded partially through its rights issue in 4QFY10. We

    are very impressed with the cutting-edge medical

    devices that MRCCC is equipped with, making it one

    of the best equipped cancer centres in Asia. SHG is

    currently generating awareness through corporations

    and private clinics. We expect higher rental incomefrom the increased capacity of MRCCC moving

    forward.

    Ground site visits highlighting tech sophistication

    and services offered: Overall, we are impressed by

    the hospital site visits. SHG has been active in

    acquiring medical devices for specialised medical

    treatment and providing a comprehensive set of

    medical services.

    First Real Estate Investment Trust

    mailto:[email protected]:[email protected]:[email protected]
  • 8/4/2019 20110930 - First Reit - Sias

    2/13

    Page 2 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Meeting the Siloam

    One of the main objectives of this FREIT trip was to learn more about the

    operator of FREITs Indonesian properties, SHG, as part of FREITs top line

    income is determined by SHGs gross revenue. SHG is one of the division arm

    of Indonesias property conglomerate, Lippo Karawaci. SHG is regarded as

    being one of the most well-organised hospitals in Indonesia, having won The

    Best Building and Managing Corporate Image in the Hospital Categroy and

    Corporate Image Index Survey by Business Week Magazine and Frontier

    Consulting Group.

    One of the takeaways from our meeting with the CFO of SHG, Romeo F. Lledo,

    is that he is very confident on the groups revenue growth in the long term,among others, by:

    (1) Providing the best in terms of operating facilities, speciallised equipment

    and services provided.

    (2) Recruiment of prominent doctor specialists under the Siloam Doctors

    Partnership Development Program (SDPDP) model of SHG.

    Ongoing efforts to increase awareness: Despite being a leader in hospital

    treatment, SHG is active in gaining exposure and establishing awareness in

    Indonesia through its marketing strategies. SHG is currently marketing check-

    up service to corporations and clinics so as to increase awareness and its

    customer base. For example, SHG is offering cheap PET/CT Scans and MRIscans to further bring awareness and as part of SHGs commitment to society.

    Building a technological moat: During this trip, we were very impressed with

    the services offered due to the number of sophisticated medical machines

    owned by SHG. For example, SHG is in charge of bringing state of the art

    machines such as the LINAC Varian with simulator for cancer treatment to their

    newly opened MRCCC.

    Base rent

    + 2 times Singapore CPI to a maximum of 2%

    + Siloam's revenue sharing scheme

    > 0% to 15% increase in gross revenue - 0.75% of gross revenue

    > 15% to 30% increase in gross revenue - 1.25% of gross revenue

    > above 30% increase in gross revenue - 2% of gross revenueSource: SIAS Research, Company

    Figure 1: Rental structure of FREITSiloams Lease Agreement

    Source: SIAS Research

    Figure 2: Marketing

    Banner By Siloam

  • 8/4/2019 20110930 - First Reit - Sias

    3/13

    Page 3 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Siloam Hospitals Lippo Village

    Siloam Hospitals Lippo Village (SHLV) was the first hospital visit in our

    agenda. This site is located in the Lippo Karawacis township, approximately

    21 kilometres away from the Soekarno-Hatta International Airport. The hospital

    is also across a road to another one of FREITs assets, Imperial Aryaduta

    Hotel & Country Club (IAHCC).

    SHLV is also a centre of excellence for neuroscience and cardiology and is

    also home to various sophisticated medical machines. SHLV is also the first in

    Indonesia to be accredited in 2007 and re-accredited in 2010 by Joint

    Commision International (JCI), the international gold standard with its key

    focus on patient safety in all its processes. With process guidelines in place,SHG can easily replicate the SHLV model to its other hospitals to be

    accredited as JCI.

    SHLV is situated at a key strategic location along the Jalan Tol Jakarta

    Freeway with easy accessibility to locals. At the same time, SHLV has great

    appeal to foreign visitors looking for specialised treatment due to its close

    proximity to the Jakarta Airport (approximately 21km away, half an hour s

    drive), next to Imperial Gold Club Lippo Karawaci and a five star hotel -

    Imperial Aryaduta Hotel and Country Club (IAHCC).

    Source: Google Map

    Figure 3: Location map of SHLV and IAHCC

    IAHCC

    SHLV

  • 8/4/2019 20110930 - First Reit - Sias

    4/13

    Page 4 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    The image of the ground floor is reminiscent of our last trip to FREITs

    hospitals where its was packed full of people queuing and hanging around the

    cafes and shops. This can be said to be similar in concept to our local

    government hospitals such as SGH and NUH.

    Facilities and Equipment: SHLV uniquely positions itself to offer specialised

    services such as MRI scans and neuro-treatment by having much more

    sophisticated treatment machines compared to other hospitals. For example,

    SHLV is one out of four hospitals in Indonesia that has the 3-tesla MRI

    machine in Indonesia. We note that SHLV aims to keep rates affordable for the

    middle income level as part of their commitment to the society.

    Source: SIAS Research Source: SIAS Research

    Figure 4: Corner Shops in SHLV Figure 5: Patients queuing in SHLV

    Source: SIAS Research

    Figure 6: Cath Lab Figure 7: Executive Medical Check-up

    & Executive Class Wards Entrance

    Source: SIAS Research

  • 8/4/2019 20110930 - First Reit - Sias

    5/13

    Page 5 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    SHLV also offers VIP patient rooms and exclusive medical checkup rooms to

    appeal to the wealthier Indonesians and for medical tourism with developed

    country citizens looking for cheaper alternatives for medical treatment. Our

    Siloam guide for the site visit also stated that family members tend to

    accompany the patient and would check in to these rooms to enjoy the sofa

    beds.

    Moving forward, SHLV is bringing in gamma knife technology which is used to

    treat brain tumors using radiation therapy. The equipment for the project costs

    approximately US$5 million which sets SHLV up to compete in medical tourism

    scene regionally. SHLV also plans to expand the size of its premise, with the

    development cost handled by Lippo Karawaci, thereby adding about 30 to 40 A

    class beds.

    Room to expand if needed: Management also stated that there are

    opportunities for expansion or services through redeveloping a portion of

    Imperial Aryaduta Hotel & Country Club (IAHCC) or working together in

    promoting medical tourism.

    Source: SIAS Research

    Figure 8: Portion of potential

    redevelopment space

  • 8/4/2019 20110930 - First Reit - Sias

    6/13

    Page 6 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Siloam Hospitals Kebon Jeruk

    Siloam Hospitals Kebon Jeruk (SHKJ) is situated in Kebon Jeruk, a

    subdistrict of West Jakarta and is approximately 8 kilometres from Central

    Jakarta. SHKJ has established itself as a Centre of Excellence in Urology and

    Orthopaedics. Similar to the other FREIT hospitals we visited, we were greeted

    by eateries located at the entrance which creates a bright atmosphere and

    relaxed environment for patients and visitors.

    We were further introduced to various top-end equipment by our Siloam guides,

    underpinning the message on what it takes to achieve the Centre of

    Excellence status. Similar to SHLV, SHKJ also offers exclusive class wards at

    a very competitive rate. Siloam Suites, the best rooms that the hospital has to

    offer, has a guest room on top of a spacious patient room, flat-screen TVs and

    personalised services.

    Adjusting to the competition: We were told that there had been recent

    competition with the opening of two hospitals launched over the past threeyears: Puri Indah Hospital and Grha Kedoya Hospital. The Siloam guide

    mentioned that SHKJ has been around for twenty years and services offered

    by them were much more comprehensive than the other two. We were also

    told that with its competitve rates and established reputation, patients generally

    put SHKJ as one of their first choice in specialised treatment.

    Source: SIAS Research

    Figure 9: Corner Shops/Waiting Area

    Source: SIAS Research

    Figure 10: Dual Source CT scanner

  • 8/4/2019 20110930 - First Reit - Sias

    7/13

    Page 7 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Mochtar Riady Comprehensive Cancer Centre

    Mochtar Riady Comprehensive Cancer Centre (MRCCC) is the latest

    Indonesian acquisition by FREIT, funded through part of net proceeds of its

    rights issue of S$167.3 million on 22 December 2010. This addition is the first

    private cancer hospital in Indonesia, offically launched on 7July 2011 by

    Indonesias President Susilo Bambang Yudhoyono. We are very impressed

    with the site and reckon it will be the flagship hospital in the region with its

    state-of-the-art facilities and equipment. Siloam intends to target patients

    seeking cancer treatment overseas due to the lack in advancement in

    Indonesias clinical and treatment technology.

    First of its kind in technological edge: MRCCC is one of the first inIndonesia to be equipped with cutting-edge medical devices such as PET-CT

    scanning and IBA Cyclotron used for cancer detection. Also, MRCCC adds to

    FREITs stable of hospitals offering one out of four MRI 3 tesla scanning

    devices in Indonesia.

    Bringing in state-of-the-art equipment: MRCCC houses some of the very

    top-end equipments and facilities in the region such as the Linac Varian with

    simulator. This machine basically provides curative treatment of cancer

    through precise radiotherapy of tumours after laser simulation. This is one of

    the most advanced forms of cancer treatment using inverse planning as

    opposed to forward planning, using pintpoint precise treatment instead of using

    trial and error.

    Personalised Hospital Treatment: MRCCC also offers personalised services

    such as helicopter lifting patients to the hospital as opposed to the

    conventional motorcycle and van ambulance. This will bypass road jams which

    is common during peak hours in Jakarta.

    Source: SIAS Research

    Figure 10: Particle Accelerator For

    Cancer Treatment

    Source: SIAS Research

    Figure 11: LINAC Varian

    http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369http://www.thejakartaglobe.com/health/indonesias-first-private-cancer-hospital-launched/451369
  • 8/4/2019 20110930 - First Reit - Sias

    8/13

    Page 8 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Not Hitting Full Capacity Yet: MRCCC is still in its infant stage with less than

    three months since its official launch. SHG is focused on creating awareness

    through offering affordable check-ups, aliasing with corporations and clinics.

    Our SHG guides also stated that the opening of MRCCC by the Indonesias

    President has generated interest from many corporations with indirect feature

    in the media.

    Source: SIAS Research

    Figure 13: Simulator used inconjunction with LINAC Varian Figure 14: Exclusive patientrooms

    Source: SIAS Research

  • 8/4/2019 20110930 - First Reit - Sias

    9/13

    Page 9 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Imperial Aryaduta Hotel and Country Club

    The 197-room five-star Imperial Aryaduta Hotel and Country Club (IAHCC) is

    situated within the Lippo Village and poised to benefit from the new shopping

    malls and upcoming developments by Lippo Karawacis development town.

    IAHCC boasts the largest country club in Indonesia with the hotel and country

    club spanning a total land area of 54,410 sqm.

    We were given a brief tour around the hotel and the country club, which gives a

    resort getaway feel with the numerous amount of facilities offered, including

    squash courts, resort pools, etc.

    To date, this asset still provides excellent asset yield at 10.2% on its fair value*.

    Moving forward, the new developments in Lippo Village will bring in more

    attractions to this area which will benefit IAHCC.

    Source: SIAS Research

    Figure 15: IAHCC Entrance

    *Based on 2010 figures

  • 8/4/2019 20110930 - First Reit - Sias

    10/13

    Page 10 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    How does this trip change our view on FREIT?

    We have gained a better understanding of the operational aspects of FREIT s

    assets and are more optimistic than before on the potential growth that FREIT

    may experience.

    Being relevant in an untapped market: Based on a quote from the health

    ministry in Indonesia, many middle to high end patients tend to seek medical

    treatment aboard due to poor healthcare offered in the country*. This market

    has been quoted to be worth approximately Rp 100 trillion (US$11.5 billion) a

    year. We believe that FREIT will stand much to gain with SHG bringing in high-

    end equipment to Indonesia without the need for large capital expenditure.

    Benefiting from Siloams operational expertise: With their operator SHG

    being active in expanding their services and awareness, FREIT stands much to

    benefit from its revenue sharing program if rendered successful. We believe

    that FREIT has much to gain from the operational expertise as well as the

    specialised equipment that SHG are providing which is imperative for

    healthcare REIT.

    Value Prospects: We are increasing the growth in FREITs distributable

    income on the basis of the outlook for the large potential of FREIT has in

    benefiting from SHG and the expanding services that they are providing. As

    mentioned before, FREIT stands to gain from these through SHGs potential

    increase in gross revenue (we highlight that this ignores any capitalexpenditure by SHG in the process of expanding their services). We maintain

    our Increase Exposurerating at an intrinsic value of S$0.965.

    *http://www.thejakartapost.com/news/2011/04/05/poor-healthcare-indonesia-boosts-medical-tourism.html

    http://www.thejakartapost.com/news/2011/04/05/poor-healthcare-indonesia-boosts-medical-tourism.htmlhttp://www.thejakartapost.com/news/2011/04/05/poor-healthcare-indonesia-boosts-medical-tourism.htmlhttp://www.thejakartapost.com/news/2011/04/05/poor-healthcare-indonesia-boosts-medical-tourism.htmlhttp://www.thejakartapost.com/news/2011/04/05/poor-healthcare-indonesia-boosts-medical-tourism.html
  • 8/4/2019 20110930 - First Reit - Sias

    11/13

    Page 11 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    S$ FY11F FY12F FY13F FY14F

    DPU 0.067 0.068 0.070 0.072

    Discount 92.3% 85.2% 78.6% 72.5%

    Explicit Value 0.227

    Terminal Value 0.737 Cost of Equity 8.4%

    Price Per Share (S$) 0.965 Terminal Growth 1.25%Source: SIAS Research

    Figure 16: Dividends Discount Model

  • 8/4/2019 20110930 - First Reit - Sias

    12/13

    Page 12 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Figure 17: Financial Forecasts and Estimates

    SGD(S$ m) FY08 FY09 FY10 FY11F

    Gross Revenue 30.2 30.2 30.3 53.0

    Income After Tax 23.0 36.0 60.5 46.0

    Distributable Income 20.8 21.0 21.3 41.7

    DPU (S$) 0.076 0.076 0.066 0.067

    Total Current Assets 14.6 13.7 41.8 48.4

    Total Non-Current Assets 324.9 340.9 612.8 595.4Total Current Liabilities 61.4 10.2 81.3 32.8

    Total Non-Current Liabilities 23.1 73.4 94.2 87.4

    Total Equity 255.1 271.0 479.1 483.7

    Net Income Before Tax 23.8 38.7 80.0 45.6

    Cash from Operating Activities 20.6 22.7 27.6 37.1

    Cash from Investing Activities 0.3 -2.0 -160.8 17.4

    Cash from Financing Activities -22.1 -25.6 153.4 -35.9

    Net Change in Cash -1.2 -4.9 20.1 18.6

    Net Cash - Beginning Balance 13.6 12.4 7.5 27.6

    Net Cash - Ending Balance 12.4 7.5 27.6 46.2

    ROE 9.0% 13.7% 16.1% 9.6%

    ROA 6.8% 10.4% 12.0% 7.1%

    Distribution yield 9.1% 9.1% 7.9% 8.7%

    Debt/Equity 0.33 0.31 0.37 0.25

    P/E 4.8 6.2 4.5 10.5

    P/B 0.9 0.9 1.1 1.0

    Source: Company, SIAS Research

  • 8/4/2019 20110930 - First Reit - Sias

    13/13

    Page 13 of13

    www.siasresearch.com UUppddaattee RReeppoorrtt

    30 Se tember 2011

    Rating Definition:

    Increase Exposure The current price of the stock is significantly lower than the underlying fundamental valuehigher level.Invest The current price of the stock is sufficiently lower than the underlying fundamental value of the firm.Readers can consider adding this stock to their portfolio.

    Fairly Valued The current price of the stock is reflective of the underlying fundamental value of the firm.Readers may not need to take actions at current price.Take Profit The current price of the stock is sufficiently higher than the underlying fundamental value of thefirm. Readers can consider rebalancing their portfolio to take advantage of the profits.

    Reduce Exposure - The current price of the stock is significantly higher than the underlying fundamental valueof the firm. Readers can consider reducing their holdings in their portfolio.

    IMPORTANT DISCLOSURE

    As of the date of this report, the analyst and his immediate family may own or have positions in any securitiesmentioned herein or any securities related thereto and may from time to time add or dispose of or may bematerially interested in any such securities. Portfolio structure should be the responsibility of the investor andthey should take into consideration their financial position and risk profile when structuring their portfolio.Investors should seek the assistance of a qualified and licensed financial advisor to help them structure theirportfolio. This research report is based on information, which we believe to be reliable. Any opinions expressedreflect our judgment at report date and are subject to change without notice. This research material is forinformation only. It does not have regards to the specific investment objectives, financial situation and theparticular needs of any specific person who may receive or access this research material. It is not to beconstrued as an offer, or solicitation of an offer to sell or buy securities referred herein. The use of this materialdoes not absolve you of your responsibility for your own investment decisions. We accept no liability for anydirect or indirect loss arising from the use of this research material. We, our associates, directors and/oremployees may have an interest in the securities and/or companies mentioned herein. This research materialmay not be reproduced, distributed or published for any purpose by anyone without our specific prior consent.